 |
Articles: General Pharma |
Prior Articles
Medtronic Highlights Positive ONSET Pediatric Diabetes Trial Results
Medtronic, 10/23/09
Free full text
Novartis delivers strong new product momentum and operational performance in first nine months of 2009
Novartis, 10/23/09
Free full text
Pixantrone Produces High Rates of Complete Remission in Multiple Relapsed and Refractory Indolent and Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 10/23/09
Free full text
Despite Health Claims by Manufacturers, Little Oversight for Homeopathic Products
JAMA, 10/23/09 Contracting private sector providers for public sector health services in Jalisco, Mexico: perspectives of system actors
Human Resources for Health, 10/23/09
Free full text
Commercial CME loses funding from second drug firm
American Medical News, 10/23/09 Ownership loses its luster: Physicians less likely to go solo
American Medical News, 10/23/09 FDA Leaders Stress Science and Compliance
BioPharm, 10/23/09
Free full text
Contracting for health and curative care use in Afghanistan between 2004 and 2005
Health Policy and Planning, 10/23/09 Merge Healthcare Marks Progress in China by Exhibiting at First Chinese Healthcare Trade Show
Imaging Economics, 10/23/09 AVI BioPharma to Present Safety Update from Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
AVI BioPharma, 10/23/09
Free full text
Adolor Corporation to Host Investor Conference Call To Report Third Quarter 2009 Financial Results
Adolor Corporation, 10/23/09
Free full text
Merck Announces Third-Quarter 2009 Financial Results
Merck & Co., 10/23/09
Free full text
Partnership for Prescription Assistance Celebrates Milestone Helping More Than 6 Million Uninsured Patients
PhRMA, 10/23/09
Free full text
Study: Ortho Docs Didnt Report All Consulting Fees
Outpatient Surgery, 10/23/09 Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference
Amylin Pharmaceuticals, 10/23/09
Free full text
ARIAD to Webcast Conference Call on Third Quarter 2009 Financial Results
ARIAD Pharmaceuticals, 10/23/09
Free full text
ImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2010 Financial Results
ImmunoGen, Inc., 10/23/09
Free full text
Inspire Announces Date for Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results
Inspire, 10/23/09
Free full text
Repligen Licenses Potential Treatment for Spinal Muscular Atrophy Conference Call Scheduled on October
Repligen, 10/23/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
